Delivery Order SPE2DB20D2104-SPE2DB24FQ69N
Award Date 10/11/23
Potential Completion Date 10/12/23
Potential Value $805
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order valued at $5,162.44 by the Defense Logistics Agency (DLA) Troop Support Medical. The order is to supply 36,000 units of Creon DR capsules in 100 count bottles to support pharmaceutical needs at DLA medical facilities. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by November 6, 2023. No set-aside designation was applied to this award made against an...
- Amerisourcebergen Drug Corporation has been awarded an $849 firm fixed price delivery order against an unidentified contract vehicle to supply 36,000 units of Creon DR capsules to the Defense Logistics Agency by October 12, 2023. The delivery order was awarded on October 11, 2023 without a set-aside designation. Performance will take place in Conshohocken, Pennsylvania. As the principal logistics agency for the Department of Defense, the Defense Logistics Agency manages the global supply chain...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical. Valued at $3,290.78, this order is for the supply of 36,000 units of Creon DR capsules to support DLA medical facilities. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with delivery required by November 1, 2023. No set aside designation was applied to this award. As a...
- Amerisourcebergen Drug Corporation has been awarded a $2,514.15 firm fixed price delivery order against an unidentified contract vehicle to supply 36,000 units of Creon DR capsules to the Defense Logistics Agency Troop Support Medical. To be performed in Conshohocken, Pennsylvania by October 2023, this unrestricted award provides 100 count bottles of pancreatic enzyme replacement therapy medications in support of DLA Troop Support Medical's provision of healthcare supplies and pharmaceuticals to...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $6,482 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide 36,000 units of Creon 36,000 capsule, 100 count bottles. Performance will take place in Conshohocken, Pennsylvania over one day in September 2023. The Defense Logistics Agency Troop Support Medical supports the Department of Defense by procuring pharmaceuticals and medical supplies. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,155.66 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules, with an ultimate completion date of July 16, 2025. This competitive, non-set-aside contract employs firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- Amerisourcebergen Drug Corporation has been awarded a $390 firm fixed price delivery order against an unidentified contracting vehicle to supply 12,000 units of Creon DR capsules to the Defense Logistics Agency by October 20, 2023. The delivery location is Conshohocken, Pennsylvania. No set-aside provisions were applied to this award to supply pancreatic enzyme replacement therapy medications in support of the Defense Logistics Agency's medical logistics responsibilities. Amerisourcebergen...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for 24,000 unit capsules of Creon DR 100s, valued at $3,406.32 with a firm fixed price structure. The contract, awarded on November 17, 2025, with an ultimate completion date of November 18, 2025, represents a non-set-aside, competitively awarded transaction. This delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $3,872 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 36,000 units of Creon DR capsules. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by November 2023. No set-aside designation was applied to this order placed under the DLA's pharmaceutical distribution program. Amerisourcebergen Drug Corp routinely...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of 24,000 unit capsules of Creon (pancrelipase) in 100-unit quantities, valued at $1,072.14. This non-competitive, firm fixed-price delivery order was awarded on January 2, 2026, with an ultimate completion date of January 5, 2026. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FQ69NDelivery Order
Amerisourcebergen Drug Corp has been awarded an $804 firm fixed price delivery order against the Defense Logistics Agency's pharmaceutical products contract vehicle. Under this contract, Amerisourcebergen will provide 36,000 units of Creon DR capsules packaged in 100 count bottles to support the DLA's medical supply needs. Performance will take place in Conshohocken, Pennsylvania, with no set-aside designation. As the DLA's mission involves maintaining readiness through worldwide management and distribution of medical equipment and supplies, this contract will deliver pancreatic enzyme replacement therapy products to aid the agency's stockpile efforts.
Generated 1/10/24, 9:04 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $805 | 10/11/23 |